Research and Development

Showing 15 posts of 9607 posts found.

better_q_image

Intelligent Automation in Pharmacovigilance

November 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, pharmacovigilance, primevigilance

PrimeVigilance is pleased to announce their collaboration with the International Society of Pharmacovigilance (ISoP) on the upcoming seminar, organised by …
eylea-product-box-md

Regeneron forced to drop Eylea combo, advantage Novartis

November 27, 2017 Manufacturing and Production, Research and Development Eylea, Novartis, Regeneron, biotech, drugs, pharma, pharmaceutical

Novartis released Phase 3 data on its leading candidate for wet age-related macular degeneration (AMD) drug and it caused a …

Recipharm equips a further three facilities for US serialisation

November 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped three more of its facilities with serialisation capabilities in …
2017-vecms_emailbanner_accel_600x200_v3

Veeva European Commercial & Medical Summit

November 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, veeva

The Veeva European Commercial & Medical Summit will begin tomorrow, seeing more than 800 industry leaders convene at the Marriot …
hiv_aids

The global HIV/AIDS movement

November 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AIDS, HIV, International HIV/AIDS Alliance

Increasingly collaborative efforts have seen the threat of HIV recede and brought hope to demographics and communities most vulnerable to …

Bayer’s $175 million pneumonia drug fails at phase 3

November 27, 2017 Research and Development, Sales and Marketing Amikacin, Amikacin Inhale, Bayer, Nektar Therapeutics, pharma

Bayer has been hit by the news that its latest effort in the pneumonia space failed at the Phase 3 …
shutterstock_138095450

Proposed cuts to National Institutes of Health could delay up to 90% of US drug approvals

November 27, 2017 Research and Development, Sales and Marketing Donald Trump, FDA, NIH, National Institutes of Health, Trump, pharma

President Donald Trump’s budget proposes to cut funding to the National Institutes of Health by $7.2 billion or 21%. Researchers …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

As Friday comes round again, this week saw some of the biggest news of the year: Amsterdam is the new …
crowd-2045498_960_720

Different gene mutations in multiple myeloma depending on ancestry

November 24, 2017 Medical Communications, Research and Development biotech, drugs, multiple myeloma, pharma, pharmaceutical

Researchers, based in the US, have conducted a large-scale collection of publicly available data and found that significant differences can …
astrazeneca_sign_sky

AZ partners with Combinations Alliance to test drug in cancer

November 24, 2017 Medical Communications, Research and Development AstraZeneca, biotech, drugs, pharma, pharmaceutical

A clinical trial is to be launched to test AstraZeneca’s experimental drug, AZD1775, for the treatment of head and neck …
640px-hiv-budding-color

Learning lessons from HIV to change the treatment access landscape

November 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, HIV, pharma

Greg Alton, Executive Vice President of Corporate and Medical Affairs at Gilead, reveals how the rapid development and distribution of …
online_survey_icon_or_logo_v2

Collaboration in Biopharma

November 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dear Colleague, Biopharmaceutical companies are increasingly partnering with a diverse set of health care stakeholders to address scientific and technological …
aedes_aegypti_mosquito

Budget cuts to the President’s Malaria Initiative could risk 67 million lives, report finds

November 22, 2017 Medical Communications, Research and Development Africa, Trump, USA, WHO, malaria, pharma

A team of researchers at Imperial College London (ICL) has argued that the proposal by US Congress to cut the …
brain-770044_960_720

‘Brain training’ found to reduce risk of dementia by 29%

November 22, 2017 Research and Development biotech, dementia, drugs, pharma, pharmaceutical

In a 10-year study conducted at the Indiana University School of Medicine, researchers were able to observe a 29% reduced …
gsk_boronia_australia

FDA approves first-ever two-drug HIV regimen, GSK’s Juluca

November 22, 2017 Research and Development, Sales and Marketing AIDS, FDA, GSK, Gilead, GlaxoSmithKilne, HIV, Juluca, ViiV Healthcare, pharma

GlaxoSmithKline has announced that the FDA has awarded US marketing authorisation to the first two-drug regimen in the treatment of …
The Gateway to Local Adoption Series

Latest content